IMIBICCórdoba, Spain
Biologist specialized in Therapeutic Targets
0094: Distinct immune-molecular signatures modulated ex vivo by JAK and TNF predict Rheumatoid Arthritis therapy outcomes in patients naïve to biologic and targeted synthetic DMARDs
Sunday, October 26, 202510:30 AM - 12:30 PM Central Time
Disclosure(s): No financial relationships with ineligible companies to disclose